Light up the Light of Life: Erdafitinib -- A New Hope for Patient
Imagine this scenario: a father in his 50s who has just been diagnosed with advanced bladder cancer. The doctor told him that after several rounds of chemotherapy, the tumor not only did not shrink, but continued to spread. Faced with such news, the whole family fell into deep despair. The side effects of chemotherapy have weakened the patient's body, and immunotherapy has not brought the expected results. At this moment, an unfamiliar name appeared in the doctor's advice - Erdafitinib Powder 99%
For most patients and their families, this name is both unfamiliar and hopeful. What exactly is it? Can it really help patients like him? Today, we will talk about this important drug that brings new light in the field of advanced bladder cancer treatment.
What is Erdafitinib?
Erdafitinib is a targeted therapy drug specifically designed for specific types of cancer. In April 2019, the US Food and Drug Administration (FDA) approved this drug, making it the first approved targeted drug for metastatic bladder cancer. On January 8, 2025, Erdafitinib was officially approved for marketing by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma carrying FGFR3 or FGFR2 gene mutations.
Simply put, Erdafitinib Powder 99% is like a "precision key" specifically designed to open the door to cancer cells carrying specific genetic mutations, preventing their growth and spread from within.
| Product name | Erdafitinib Powder 99% |
| CAS | 1346242-81-6 |
| Molecular formula | C25H30N6O2 |
| Molecular weight | 446.54 |
| EINECS Number | 610-261-8 |
| melting point | 136-140°C |
| solubility | NA |
| Storage conditions | Store at room temperature and avoid light exposure |
| Appearance | Yellow powder |
| boiling point | 662.3±55.0 °C |
| Density | 1.20±0.1 g/cm3 |
Product Specification
| Items | Specification | Results |
| Appearance | Yellow solid | Conforms |
| NMR | Conforms to structure | Conforms |
| Infrared Spectrum | Conforms to structure | Conforms |
| Assay | ≥98.5% | 99.40% |
| Conclusion | Conform with enterprise specification . | |
Mechanism of action: a precise 'molecular key'
To understand the role of Erdafitinib, we first need to understand an important concept - FGFR. What is FGFR?
FGFR (fibroblast growth factor receptor) is a type of protein that exists on the surface of cells. They act as "antennas" on the cell surface, responsible for receiving external signals and transmitting them to the inside of the cell Under normal circumstances, these "antennas" help cells grow, differentiate, and repair However, in some cancers, these "antennas" may exhibit abnormalities - genetic mutations cause them to remain in an "on" state, constantly sending "growth" signals to cells, ultimately leading to uncontrolled proliferation of cancer cells.
How does Erdafitinib work?
The mechanism of action of Erdafitinib Powder 99% is very clever It is a small molecule tyrosine kinase inhibitor that selectively binds to FGFR, like a specially designed "lock" that precisely inserts into the "keyhole" of FGFR, preventing its activation Specifically:
Blocking signal transduction: After binding to FGFR, it blocks the abnormal activation of the FGFR signaling pathway;
Inhibiting tumor growth: By blocking signals, inhibiting the proliferation, differentiation, and migration of tumor cells;
Promoting cancer cell apoptosis: causing cancer cells to lose their survival signal and ultimately move towards death;
This "precision strike" method is in stark contrast to the traditional chemotherapy drugs' indiscriminate attack on rapidly dividing cells Erdafitinib only targets cancer cells carrying FGFR gene mutations and causes relatively less damage to normal cells.
Target audience: Who is most suitable for using Erdafitinib?
Localized advanced or metastatic urothelial carcinoma:
This is the most common type of bladder cancer, originating from urothelium.
Patients who have failed previous treatments:
Patients who typically experience disease progression during or after chemotherapy.
FGFR gene mutation patients:
Genetic testing must be conducted to confirm the presence of FGFR3 or FGFR2 gene variants.
Immunotherapy ineffective patients:
Patients who experience disease progression during or after anti-PD-1 or anti-PD-L1 treatment.
Clinical efficacy: hope behind data
According to the clinical trial data of BLC2001:
Objective response rate (ORR): After treatment, 87 patients with advanced bladder cancer with FGFR gene mutation had an ORR of 32.2%; Updated data shows that the ORR of 99 patients reached 40%;
After immunotherapy, 22 patients had an ORR of up to 59%;
Median overall survival: 13.8 months, reducing the risk of death by 36% compared to traditional chemotherapy;
Median duration of relief: 5.4 months;
These data suggest that for patients carrying FGFR gene mutations, a considerable proportion of patients will experience a significant reduction in tumor size, and even some patients will have their tumors completely disappear, after using Erdafitinib.
Comparison with traditional chemotherapy:
Compared to traditional chemotherapy, Erdafitinib has no differential mode of action in killing rapidly dividing cells and accurately targeting FGFR mutant cancer cells. It is widely applicable to a wide range of populations and does not rely on genetic testing. Only FGFR mutant patients have severe bone marrow suppression, common mild hair loss, common rare gastrointestinal reactions, severe gastrointestinal reactions, relatively mild, and poor tolerance
From these data, it can be seen that EErdafitinib Powder 99% has demonstrated unique advantages in both efficacy and safety, especially for patients who are not sensitive to traditional chemotherapy and immunotherapy.
How to purchase Erdafitinib from Faithful?
Xi'an Faithful BioTech Co.,Ltd is the manufacturers and suppliers of API in China, and warehouse in Germany and USA of California, which can quickly and safely deliver to your address.
Our address:
Unit 1301, Building 2, Daxing Jiuzhen, Daxing East Road, Lianhu District, Xi'an City, Shaanxi Province, China
Phone Number:
E-mail:
A variety of shipping methods for you to choose
| Transportation Time | Shipping method | Cargo weight requirements | Advantage |
| 3-7 days | DHL, Germany DHL, Germany DPD, UPS, USPS,FedEx, TNT,EMS |
Suitable for under 50kg. International door to door express |
We have warehouses in Germany and California, USA, and customers in Europe and America can enjoy sending goods directly from these two places. |
| 7-15 days | By Air | Suitable for more than 50kg. fast and cheaper for large order |
|
| 15-60 days | By Sea | Suitable for more than 500kg. Cheapest shipping way |
Send your Inquiry for more details,Click email:sales2@faithfulbio.comor Whatsapp:+86 17782785148 Now.
FAQ
01.What quality assurance measures does your company have in place?
We maintain rigorous quality control and assurance processes to ensure that our products meet industry standards and regulatory requirements. Our facilities are compliant with Good Manufacturing Practices (GMP).
02.Does your company ship products internationally?
03. How can I track my order once it's shipped?
Disclaimer: The information provided on this website is for reference only and does not guarantee the accuracy, validity, timeliness, or completeness of the information. Please filter carefully. If you believe that this article infringes, please contact the administrator. We are not responsible for any consequences of the information and services on this website.
Note: This compound is only used for laboratory research purposes. The US authorities have not evaluated these claims. Before use, please consult your doctor and learn about available research. This product is not intended for the diagnosis, treatment, cure, or prevention of any disease.
Hot Tags: erdafitinib powder 99% cas 1346242-81-6, China, suppliers, manufacturers, factory, customized, wholesale, buy, price, bulk, pure, producer, discount, for sale, in stock, free sample, raw powder, raw material, made in China